Digicon

@if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif

@if (isset(session()->get('doctor')['vCentralCode']))

Logout

@endif

@csrf

@if (isset(session()->get('doctor')['vCentralCode']))

Back

@else

@endif

Patient {{ $iPatientNo }}

Q1: What would be the percentage of Respiratory tract infection patients in your practice? *

a) 10% b) 20% c) 30% d) >30%

Q2: Which age group URTI cases are more common? *

a) Pediatric b) Geriatric c) Adults d) Do not know

Q3: Which age group is commonly affected by RTI? *

a) 10 Years and less b) 10 to 20 years c) 20 to 50 Years d) 50 Years and above

Q4: How many patients of community-acquired pneumonia do you see in your practice out of 100? *

a) < 10% b) 10% to 20% c) 21% to 30% d) > 30%

Q5: How many patients of Pharyngitis do you see in your practice out of 100? *

a) < 10%

b) 10% to 20%

c) 21% to 30%

d) > 30%

Q6: How many patients of tonsillitis do you see in your practice out of 100? *

a) < 10%

b) 10% to 20%

c) 21% to 30%

d) > 30%

Q7: How many patients of Sinusitis do you see in your practice out of 100? *

a) < 10%

b) 10% to 20%

c) 21% to 30%

d) > 30%

Q8: How many patients of middle ear infections do you see in your practice out of 100? *

a) < 10%

b) 10% to 20%

c) 21% to 30%

d) > 30%

Q9: How many patients of LRTI do you see in your practice out of 100? *

a) < 10%

b) 10% to 20%

c) 21% to 30%

d) > 30%

Q10: How many patients of SSTI do you see in your practice out of 100? *

a) < 10%

b) 10% to 20%

c) 21% to 30%

d) > 30%

Q11: Which anti-infective do you prefer to treat Upper respiratory tract infections? *

a) Beta-lactam

b) Cephalosporins

c) Macrolides

d) Fluoroquinolones

e) Any Other

If any Other, please specify

Q12: What would be the most common duration of anti-infective therapy for Upper respiratory tract infection? *

a) 3 days

b) 5 days

c) More than 5 days

d) Other

If other, please specify

Q13: Which molecule has shown increased resistance with Beta-lactam? *

a) Beta-lactam

b) Cephalosporins

c) Macrolides

d) Fluoroquinolones

e) Other

If other, please specify

Q14: Do comorbidities impact your decision of selecting a molecule? *

a) Yes b) No c) Do not Know

Q15: How common are added anaerobic infections in URTI? *

a) <10% b) 10% to 20% c) 21% to 30% d) >30%